2969 |
Vulnerable Plaque Is a Systemic Disease: Insights from BioImage |
Roxana Mehran |
Apr. 21. 16 |
2968 |
The Promise of Regenerative Therapies for CLI |
Krishna Rocha-Singh |
Apr. 21. 16 |
2967 |
Clinical Impact of Routine FFR Measurement |
Jung-Min Ahn |
Apr. 21. 16 |
2966 |
Optimal Medical Therapy for the CLI Patient - Does It Make a Difference? |
John Robert Laird, Jr. |
Apr. 21. 16 |
2965 |
Tandem |
Jung-Min Ahn |
Apr. 21. 16 |
2964 |
CLI - Insights from the OLIVE Registry |
Osamu Iida |
Apr. 21. 16 |
2963 |
Bifurcation |
Bon-Kwon Koo |
Apr. 21. 16 |
2962 |
Cost Effectiveness of Endovascular Procedures - Can We Afford These Expensive Technologies? |
Mark W. Burket |
Apr. 21. 16 |
2961 |
Left Main |
William F. Fearon |
Apr. 21. 16 |
2960 |
Atherectomy Followed by Drug Coated Balloon Angioplasty - Is This the Holy Grail? |
Lawrence A. Garcia |
Apr. 21. 16 |